Quality & complianceOfficial
Gabapentin Orion 600 mg supply problem in Denmark expected to run into early 2027
🇩🇰 DKMA · Thu 19 Nov 2026
The Danish Medicines Agency lists a supply difficulty for Orion Pharma's 600 mg gabapentin tablets, attributed to increased sales and demand, expected from August 2026 to early February 2027.
The Danish Medicines Agency (DKMA) has published a supply notice for Gabapentin "Orion" 600 mg film-coated tablets, marketed by Orion Pharma A/S. The notice, dated 19 November 2026, says there are current problems with supply of the product.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.
More Quality & compliance
All →
Terumo Aortic recalls all in-date Relay Pro and Treo stent-graft systems over endotoxin risk
🇨🇦 Health Canada · Fri 20 Nov 2026
FDA says clinical investigator's CAPA response falls short after CBER warning letter
🇺🇸 FDA CBER · Fri 20 Nov 2026
BfArM publishes GE Healthcare urgent field safety notice for Centricity PACS and Enterprise Archive
🇩🇪 BfArM field safety notices · Fri 20 Nov 2026
New Jersey health centre owner jailed for 180 days over billing fraud and unlicensed practice
🇺🇸 HHS OIG · Fri 20 Nov 2026
Richmond couple sentenced over Medicaid mental health billing scheme worth nearly $1m
🇺🇸 HHS OIG · Fri 20 Nov 2026
InnovAge settles Colorado Medicaid false claims allegations over senior care services
🇺🇸 HHS OIG · Fri 20 Nov 2026